186 results
Page 6 of 10
6-K
EX-99.5
4lguy9 ccaebao7vl3
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
of8l5htcm ablz5ebm4
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
z07gxu50
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.2
2mo2z3bosox4vbzv3b
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.3
9cp3g hrv20kn65ne
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
6rbwir 9sb7kj0b5
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
p4dzbx 4y99n8nh3d2bz
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.2
s4290oc n0xh2o2fg
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.1
kkcnq82 hf
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.1
tdrlnz
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.2
17r98om29no8jiwe
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
to3q7j 9d1
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
obdyc
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
yjh3rac
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.1
id281koj1 qqngz3rv17
6 Mar 19
51-102F3 Material Change Report
4:53pm
6-K
EX-99.1
4hp5ag4570n4n0
5 Mar 19
RepliCel CEO Provides 2019 Shareholder Update
10:41am
6-K
EX-99.1
qx63sl
23 Jan 19
51-102F3 Material Change Report
12:44pm
6-K
EX-99.2
b2i6wpizt2f2ymy7r9j
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.1
4sboiep 4v9wqnl
26 Nov 18
Current report (foreign)
4:20pm